{
    "clinical_study": {
        "@rank": "43487", 
        "arm_group": [
            {
                "arm_group_label": "SIRS, SEPSIS"
            }, 
            {
                "arm_group_label": "sepsis, severe sepsis, septic shock"
            }, 
            {
                "arm_group_label": "health, SIRS, Sepsis"
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the potential value of alpha-1-acid glycoprotein (AGP) for early diagnosis and\n      prognosis of patients with sepsis, and then compared with C-reactive protein (CRP),\n      procalcitonin (PCT), white blood cell (WBC) counts, Acute Physiology and Chronic Health\n      Evaluation (APACHE) II score and Sequential Organ Failure Assessment (SOFA) score. 164\n      patients were enrolled in the study, including 25 cases with systemic inflammatory response\n      syndrome (SIRS) and 139 cases with different levels of sepsis (46 moderate sepsis, 52 severe\n      sepsis and 41 septic shock ). Serum levels of Alpha-1-acid Glycoprotein (AGP), C-reactive\n      protein (CRP), and procalcitonin (PCT), and white blood cell (WBC) counts were measured on\n      the day of admission to intensive care unit (ICU)."
        }, 
        "brief_title": "Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in Sepsis", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Systemic Inflammatory Response Syndrome", 
            "Sepsis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia", 
                "Systemic Inflammatory Response Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male and female aged 18 years old and over;\n\n          2. Clinically suspected infection;\n\n          3. Fulfilled at least two criteria of systemic inflammatory response syndrome (a) core\n             temperature higher than 38 \u00b0C or lower than 36 \u00b0C (b)respiratory rate above 20/min,\n             or PCO2 below 32 mmHg (c) pulse rate above 90/min, and (d) white blood cell count\n             greater than 12,000/\u03bcl or lower than < 4,000/\u03bcl or less than 10% of bands;\n\n        Exclusion Criteria:\n\n          1. less than 18 years old;\n\n          2. immunosuppression;\n\n          3. agranulocytosis (granulocyte counts <0.5\u00d7 109/L);\n\n          4. chronic myeloid leukemia (CML);\n\n          5. malignancy;\n\n          6. less than 24 hours of the length of ICU stay;\n\n          7. reluctant to participate in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Between April 2011 and APRIL 2013, inpatients were included who were in the intensive care\n        units (ICU) of the Department of Respiratory Disease (RICU), the Emergency Department\n        (EICU), and the Department of Surgery (SICU) of the Chinese People's Liberation Army\n        General Hospital."
            }
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838525", 
            "org_study_id": "20130419-007"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sepsis", 
            "alpha-1-acid glycoprotein (AGP)", 
            "diagnosis", 
            "prognosis", 
            "SIRS"
        ], 
        "lastchanged_date": "April 23, 2013", 
        "location": {
            "contact": {
                "email": "xielx@263.net", 
                "last_name": "Lixin Xie, doctor", 
                "phone": "+86 010 55499130"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100853"
                }, 
                "name": "Chinese PLA General Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "3", 
        "overall_contact": {
            "email": "xiaok301@163.com", 
            "last_name": "Kun Xiao, graduate", 
            "phone": "+86 13716608331"
        }, 
        "overall_official": {
            "affiliation": "Department Of Respiratory Diseases, Chinese PLA General Hospital", 
            "last_name": "Lixin Xie, doctor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The survival time of patients more than 28 days is defined as survival. The survival time of patients less than 28 days is defined as death", 
            "measure": "Patients Outcome", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838525"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chinese PLA General Hospital", 
            "investigator_full_name": "Longxiang Su", 
            "investigator_title": "Attending Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Chinese PLA General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chinese PLA General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}